Authors: Fornaciari, G Salvarani, C Beltrami, M Macchioni, P Stockbrugger, RW Russel, MG

Citation: G. Fornaciari et al., Muscoloskeletal manifestations in inflammatory bowel disease, CAN J GASTR, 15(6), 2001, pp. 399-403

Authors: Vecchi, M Meucci, G Gionchetti, P Beltrami, M Di Maurizio, P Beretta, L Ganio, E Usai, P Campieri, M Fornaciari, G De Franchis, R

Citation: M. Vecchi et al., Oral versus combination mesalazine therapy in active ulcerative colitis: adouble-blind, double-dummy, randomized multicentre study, ALIM PHARM, 15(2), 2001, pp. 251-256

Authors: Salvarani, C Vlachonikolis, IG van der Heijde, DM Fornaciari, G Maechioni, P Beltrami, M Olivieri, I Di Gennaro, F Politi, P Stockbrugger, RW Russel, MG

Citation: C. Salvarani et al., Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients, SC J GASTR, 36(12), 2001, pp. 1307-1313

Authors: Witte, J Shivananda, S Lennard-Jones, JE Beltrami, M Politi, P Bonanomi, C Tsianos, EV Mouzas, I Schulz, TB Monteiro, E Clofent, J Odes, S Limonard, CB Stockbrugger, RW Russel, MG

Citation: J. Witte et al., Disease outcome in inflammatory bowel disease: Mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD), SC J GASTR, 35(12), 2000, pp. 1272-1277